Evaluation of Pharmacodynamic Effects on Ovulation and Cycle Control

• Status: Completed
• Trial end date: 2008-02-01

Summary

Evaluate the adequacy of ovulation suppression, cycle control, and safety of three transdermal contraceptive delivery systems (TCDSs).

• Phase: Phase 2

Details

• Lead Sponsor: Agile Therapeutics
• Treatments: Contraceptive Agents; Estradiol; Estradiol 17 beta-cypionate; Estradiol 3-benzoate; Estradiol valerate; Ethinyl Estradiol; Ethinyl estradiol, levonorgestrel drug combination; Levonorgestrel; Polyestradiol phosphate